Genetic testing has a role in the care of patients with neuroendocrine tumors (NETs), especially in younger patients with NETs and in cases of NETs......READ MORE
Small-bowel neuroendocrine tumors (NETs) will eventually progress during ongoing somatostatin analogue (SSA) therapy. Treatment options for progres......READ MORE
Advanced well-differentiated neuroendocrine tumors (NETs) of the small intestine often secrete vasoactive substances that can cause carcinoid syndr......READ MORE
Small bowel neuroendocrine tumors (NETs), which may be associated with carcinoid syndrome, are often metastatic at presentation. Somatostatin analo......READ MORE
Both cross-sectional imaging and functional imaging with somatostatin receptor (SSTR)–based positron emission tomography (PET) can offer important ......READ MORE
